HeartBeam, Inc., , a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that its groundbreaking synthesized 12-lead ...

Milestone results formed the basis of HeartBeam’s 12-lead ECG synthesis software application submitted ... Forward-Looking Statements All statements in this release that are not based on historical ...

The global Holter ECG Market, valued at US$0.44 billion in 2024, is forecasted to grow at a robust CAGR of 6.5%, reaching ...

The global Holter ECG Market, valued at US$0.44 billion in 2024, is forecasted to grow at a robust CAGR of 6.5%, reaching US$0.49 billion in 2025 ...

HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused on transforming ECGs/EKGs to save lives ...

HeartBeam rolled out an application for its 12-lead ECG synthesis software to the FDA, based on the data from the study.